Yong-Moon Park
Concepts (254)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obesity | 29 | 2023 | 1113 | 5.300 |
Why?
| Diabetes Mellitus, Type 2 | 18 | 2024 | 467 | 4.370 |
Why?
| Diet, Mediterranean | 8 | 2023 | 10 | 4.280 |
Why?
| Nutrition Surveys | 28 | 2023 | 104 | 4.100 |
Why?
| Breast Neoplasms | 12 | 2024 | 1169 | 3.370 |
Why?
| Republic of Korea | 36 | 2024 | 54 | 3.130 |
Why?
| Insulin Resistance | 13 | 2018 | 264 | 3.070 |
Why?
| Hypertension | 11 | 2023 | 532 | 2.780 |
Why?
| Cardiovascular Diseases | 13 | 2024 | 440 | 2.580 |
Why?
| Blood Glucose | 14 | 2022 | 432 | 2.400 |
Why?
| Body Mass Index | 28 | 2022 | 652 | 2.390 |
Why?
| Risk Factors | 47 | 2024 | 3619 | 2.330 |
Why?
| Diet | 10 | 2023 | 564 | 1.940 |
Why?
| Middle Aged | 64 | 2024 | 11997 | 1.850 |
Why?
| Female | 82 | 2024 | 26329 | 1.760 |
Why?
| Inflammation | 4 | 2022 | 604 | 1.610 |
Why?
| Adult | 57 | 2024 | 13160 | 1.600 |
Why?
| Overweight | 6 | 2019 | 219 | 1.600 |
Why?
| Triglycerides | 7 | 2020 | 159 | 1.460 |
Why?
| Siblings | 3 | 2021 | 33 | 1.450 |
Why?
| Prospective Studies | 21 | 2023 | 2344 | 1.450 |
Why?
| Humans | 95 | 2024 | 49827 | 1.440 |
Why?
| Metformin | 2 | 2021 | 64 | 1.420 |
Why?
| Cross-Sectional Studies | 21 | 2023 | 1541 | 1.350 |
Why?
| Health Surveys | 7 | 2020 | 232 | 1.300 |
Why?
| Diabetes Mellitus | 7 | 2023 | 283 | 1.280 |
Why?
| F2-Isoprostanes | 4 | 2023 | 8 | 1.250 |
Why?
| Postmenopause | 6 | 2022 | 100 | 1.240 |
Why?
| Feeding Behavior | 5 | 2022 | 181 | 1.240 |
Why?
| Aged | 40 | 2024 | 9272 | 1.200 |
Why?
| Income | 3 | 2024 | 99 | 1.150 |
Why?
| Blood Pressure | 12 | 2020 | 514 | 1.140 |
Why?
| Male | 57 | 2024 | 25093 | 1.120 |
Why?
| Aging | 5 | 2022 | 688 | 1.070 |
Why?
| Prevalence | 15 | 2023 | 943 | 1.030 |
Why?
| Waist Circumference | 11 | 2020 | 19 | 1.030 |
Why?
| Oxidative Stress | 5 | 2023 | 768 | 1.010 |
Why?
| Proportional Hazards Models | 12 | 2022 | 406 | 0.950 |
Why?
| Esophageal Neoplasms | 2 | 2022 | 99 | 0.940 |
Why?
| Cataract | 2 | 2015 | 45 | 0.910 |
Why?
| Premenopause | 6 | 2018 | 24 | 0.900 |
Why?
| Incidence | 14 | 2024 | 1003 | 0.900 |
Why?
| Attention Deficit Disorder with Hyperactivity | 2 | 2014 | 173 | 0.840 |
Why?
| Isoprostanes | 1 | 2022 | 2 | 0.830 |
Why?
| United States | 19 | 2023 | 4838 | 0.800 |
Why?
| Atrial Fibrillation | 1 | 2024 | 177 | 0.790 |
Why?
| Young Adult | 14 | 2020 | 3936 | 0.790 |
Why?
| Periodontitis | 3 | 2019 | 10 | 0.780 |
Why?
| Neoplasms | 4 | 2024 | 1233 | 0.770 |
Why?
| Hypoglycemia | 5 | 2022 | 48 | 0.770 |
Why?
| Cholesterol | 7 | 2021 | 146 | 0.770 |
Why?
| Diabetes, Gestational | 2 | 2022 | 53 | 0.740 |
Why?
| Body Weight | 5 | 2019 | 513 | 0.740 |
Why?
| Cholesterol, HDL | 8 | 2021 | 36 | 0.730 |
Why?
| Age Factors | 6 | 2020 | 1090 | 0.710 |
Why?
| Risk Assessment | 4 | 2019 | 1262 | 0.670 |
Why?
| Phenotype | 6 | 2023 | 727 | 0.660 |
Why?
| Follow-Up Studies | 13 | 2021 | 2179 | 0.650 |
Why?
| Acidosis | 1 | 2018 | 40 | 0.650 |
Why?
| Cohort Studies | 18 | 2022 | 1422 | 0.640 |
Why?
| Adenocarcinoma | 1 | 2022 | 401 | 0.640 |
Why?
| Intraocular Pressure | 2 | 2016 | 50 | 0.630 |
Why?
| Physical Fitness | 2 | 2015 | 54 | 0.620 |
Why?
| Odds Ratio | 6 | 2018 | 548 | 0.610 |
Why?
| Plaque, Atherosclerotic | 1 | 2018 | 38 | 0.610 |
Why?
| Diabetic Angiopathies | 2 | 2018 | 18 | 0.590 |
Why?
| Coronary Artery Disease | 2 | 2018 | 274 | 0.590 |
Why?
| Hypertriglyceridemia | 2 | 2014 | 13 | 0.570 |
Why?
| Glaucoma, Open-Angle | 1 | 2016 | 18 | 0.570 |
Why?
| Alanine Transaminase | 2 | 2014 | 124 | 0.560 |
Why?
| Breast Feeding | 1 | 2018 | 184 | 0.560 |
Why?
| Insulin | 2 | 2018 | 457 | 0.550 |
Why?
| Aged, 80 and over | 9 | 2018 | 3125 | 0.530 |
Why?
| Nutrition Assessment | 4 | 2021 | 63 | 0.520 |
Why?
| Ideal Body Weight | 1 | 2015 | 6 | 0.510 |
Why?
| Lipids | 2 | 2015 | 147 | 0.510 |
Why?
| Muscles | 1 | 2015 | 103 | 0.510 |
Why?
| Lipoproteins | 1 | 2015 | 39 | 0.510 |
Why?
| Energy Metabolism | 1 | 2017 | 281 | 0.490 |
Why?
| Zinc | 1 | 2015 | 53 | 0.490 |
Why?
| Metabolic Diseases | 1 | 2015 | 40 | 0.490 |
Why?
| Antihypertensive Agents | 2 | 2012 | 115 | 0.470 |
Why?
| Diabetic Retinopathy | 1 | 2014 | 40 | 0.450 |
Why?
| Body Composition | 1 | 2015 | 318 | 0.440 |
Why?
| Sex Factors | 6 | 2017 | 693 | 0.440 |
Why?
| Sarcopenia | 1 | 2014 | 84 | 0.430 |
Why?
| Bipolar Disorder | 1 | 2014 | 192 | 0.430 |
Why?
| Exercise | 5 | 2024 | 490 | 0.430 |
Why?
| Ferritins | 1 | 2012 | 29 | 0.420 |
Why?
| Depressive Disorder, Major | 1 | 2014 | 151 | 0.420 |
Why?
| Menopause | 1 | 2013 | 55 | 0.410 |
Why?
| Stroke | 5 | 2024 | 492 | 0.410 |
Why?
| Dinoprost | 3 | 2022 | 8 | 0.400 |
Why?
| Adipose Tissue | 1 | 2013 | 187 | 0.400 |
Why?
| Fasting | 3 | 2018 | 69 | 0.390 |
Why?
| Prognosis | 8 | 2021 | 1952 | 0.390 |
Why?
| Socioeconomic Factors | 4 | 2018 | 580 | 0.390 |
Why?
| Diabetes Complications | 1 | 2012 | 118 | 0.390 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2012 | 488 | 0.380 |
Why?
| Comorbidity | 3 | 2018 | 618 | 0.340 |
Why?
| Anti-Mullerian Hormone | 1 | 2018 | 4 | 0.330 |
Why?
| Meat | 2 | 2019 | 55 | 0.330 |
Why?
| Hypoglycemic Agents | 2 | 2021 | 166 | 0.320 |
Why?
| Dietary Fats | 1 | 2018 | 133 | 0.310 |
Why?
| Glucose Intolerance | 2 | 2019 | 27 | 0.300 |
Why?
| Retrospective Studies | 11 | 2024 | 6117 | 0.290 |
Why?
| Sex Distribution | 4 | 2015 | 135 | 0.290 |
Why?
| Myocardial Infarction | 3 | 2020 | 382 | 0.290 |
Why?
| Medicaid | 3 | 2014 | 257 | 0.290 |
Why?
| Colorectal Neoplasms | 2 | 2020 | 234 | 0.280 |
Why?
| Obesity, Abdominal | 3 | 2022 | 13 | 0.280 |
Why?
| Cardiovascular System | 2 | 2018 | 49 | 0.270 |
Why?
| Energy Intake | 2 | 2022 | 170 | 0.260 |
Why?
| Autonomic Nervous System | 2 | 2018 | 57 | 0.260 |
Why?
| Case-Control Studies | 3 | 2021 | 1128 | 0.250 |
Why?
| Anthracyclines | 1 | 2024 | 24 | 0.230 |
Why?
| Logistic Models | 3 | 2018 | 891 | 0.230 |
Why?
| Cause of Death | 2 | 2022 | 145 | 0.220 |
Why?
| Receptors, Estrogen | 2 | 2021 | 130 | 0.220 |
Why?
| Educational Status | 2 | 2015 | 222 | 0.220 |
Why?
| Cooking | 2 | 2019 | 22 | 0.220 |
Why?
| Survivors | 1 | 2024 | 125 | 0.220 |
Why?
| Health Status | 2 | 2015 | 298 | 0.210 |
Why?
| Antibodies, Bacterial | 2 | 2019 | 27 | 0.210 |
Why?
| Adolescent | 6 | 2023 | 6340 | 0.210 |
Why?
| Lutein | 1 | 2022 | 10 | 0.210 |
Why?
| beta Carotene | 1 | 2022 | 12 | 0.210 |
Why?
| Nutritional Physiological Phenomena | 1 | 2022 | 22 | 0.200 |
Why?
| Time Factors | 5 | 2020 | 2912 | 0.200 |
Why?
| Laryngeal Neoplasms | 1 | 2022 | 42 | 0.200 |
Why?
| ROC Curve | 2 | 2014 | 232 | 0.200 |
Why?
| Carotenoids | 1 | 2022 | 49 | 0.200 |
Why?
| Plant Proteins | 1 | 2022 | 70 | 0.200 |
Why?
| Korea | 3 | 2023 | 7 | 0.190 |
Why?
| Risk | 2 | 2019 | 320 | 0.190 |
Why?
| Sleep | 2 | 2021 | 182 | 0.180 |
Why?
| Cardiac Surgical Procedures | 2 | 2013 | 298 | 0.180 |
Why?
| Survival Rate | 3 | 2020 | 905 | 0.170 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2019 | 42 | 0.170 |
Why?
| Breakfast | 1 | 2019 | 15 | 0.170 |
Why?
| Hyperglycemia | 1 | 2019 | 79 | 0.170 |
Why?
| Parkinson Disease | 1 | 2021 | 152 | 0.160 |
Why?
| Hydrogen-Ion Concentration | 1 | 2018 | 174 | 0.160 |
Why?
| Rural Population | 3 | 2013 | 535 | 0.160 |
Why?
| Epigenesis, Genetic | 1 | 2022 | 373 | 0.160 |
Why?
| Child | 4 | 2014 | 6824 | 0.160 |
Why?
| Vegetables | 1 | 2018 | 73 | 0.160 |
Why?
| Mouth | 1 | 2018 | 33 | 0.160 |
Why?
| Glycemic Index | 1 | 2018 | 5 | 0.160 |
Why?
| Carcinoma, Hepatocellular | 1 | 2020 | 194 | 0.150 |
Why?
| Periodontal Index | 2 | 2016 | 9 | 0.150 |
Why?
| Diabetic Neuropathies | 1 | 2018 | 49 | 0.150 |
Why?
| South Carolina | 2 | 2014 | 23 | 0.150 |
Why?
| Hypercholesterolemia | 1 | 2017 | 36 | 0.150 |
Why?
| Fruit | 1 | 2018 | 136 | 0.150 |
Why?
| Cluster Analysis | 1 | 2018 | 235 | 0.150 |
Why?
| Waist-Hip Ratio | 1 | 2017 | 6 | 0.150 |
Why?
| Tonometry, Ocular | 1 | 2016 | 5 | 0.140 |
Why?
| Dementia | 1 | 2018 | 141 | 0.140 |
Why?
| Stomach Neoplasms | 1 | 2020 | 174 | 0.140 |
Why?
| Brain Ischemia | 1 | 2018 | 161 | 0.140 |
Why?
| Liver Neoplasms | 1 | 2020 | 332 | 0.140 |
Why?
| Anthropometry | 1 | 2016 | 92 | 0.140 |
Why?
| C-Reactive Protein | 1 | 2016 | 142 | 0.130 |
Why?
| Blepharoptosis | 1 | 2015 | 13 | 0.130 |
Why?
| Alcohol Drinking | 2 | 2015 | 223 | 0.130 |
Why?
| Kidney Failure, Chronic | 1 | 2017 | 197 | 0.130 |
Why?
| Reference Values | 1 | 2015 | 310 | 0.130 |
Why?
| Texas | 1 | 2015 | 137 | 0.130 |
Why?
| Adrenergic Uptake Inhibitors | 1 | 2014 | 15 | 0.120 |
Why?
| Patient Compliance | 1 | 2016 | 230 | 0.120 |
Why?
| Conduct Disorder | 1 | 2014 | 9 | 0.120 |
Why?
| Age Distribution | 1 | 2015 | 170 | 0.120 |
Why?
| Myopia | 1 | 2014 | 7 | 0.120 |
Why?
| Neoplasm Staging | 1 | 2017 | 746 | 0.120 |
Why?
| Food Supply | 1 | 2015 | 91 | 0.120 |
Why?
| Social Class | 1 | 2015 | 94 | 0.120 |
Why?
| Toothbrushing | 1 | 2013 | 2 | 0.120 |
Why?
| Metabolome | 1 | 2015 | 88 | 0.120 |
Why?
| Linear Models | 1 | 2015 | 281 | 0.120 |
Why?
| Exercise Test | 1 | 2014 | 121 | 0.120 |
Why?
| Health Status Indicators | 1 | 2014 | 83 | 0.120 |
Why?
| Anxiety Disorders | 1 | 2014 | 126 | 0.120 |
Why?
| Asthma | 1 | 2017 | 283 | 0.120 |
Why?
| Pregnancy | 2 | 2022 | 2584 | 0.120 |
Why?
| Metabolomics | 1 | 2015 | 124 | 0.110 |
Why?
| Vitamin D Deficiency | 1 | 2014 | 44 | 0.110 |
Why?
| Vitamin D | 1 | 2014 | 88 | 0.110 |
Why?
| Analysis of Variance | 1 | 2015 | 565 | 0.110 |
Why?
| Organ Size | 1 | 2014 | 226 | 0.110 |
Why?
| Ibuprofen | 1 | 2013 | 21 | 0.110 |
Why?
| Smoking | 2 | 2015 | 510 | 0.110 |
Why?
| Ductus Arteriosus, Patent | 1 | 2013 | 34 | 0.110 |
Why?
| Sex Characteristics | 2 | 2015 | 190 | 0.110 |
Why?
| Anti-Arrhythmia Agents | 1 | 2013 | 79 | 0.110 |
Why?
| Voluntary Health Agencies | 1 | 2012 | 4 | 0.110 |
Why?
| Tachycardia, Supraventricular | 1 | 2013 | 40 | 0.110 |
Why?
| International Agencies | 1 | 2012 | 13 | 0.110 |
Why?
| Heart Septal Defects, Atrial | 1 | 2013 | 44 | 0.110 |
Why?
| Leukocyte Count | 1 | 2013 | 70 | 0.110 |
Why?
| Cardiovascular Agents | 1 | 2013 | 54 | 0.110 |
Why?
| Albuminuria | 1 | 2012 | 47 | 0.110 |
Why?
| Absorptiometry, Photon | 1 | 2013 | 154 | 0.110 |
Why?
| Awareness | 1 | 2012 | 29 | 0.100 |
Why?
| Central Nervous System Stimulants | 1 | 2014 | 213 | 0.100 |
Why?
| Catheter Ablation | 1 | 2013 | 121 | 0.100 |
Why?
| Sensitivity and Specificity | 1 | 2014 | 854 | 0.100 |
Why?
| Disease Management | 1 | 2013 | 174 | 0.100 |
Why?
| Severity of Illness Index | 3 | 2020 | 942 | 0.100 |
Why?
| Needs Assessment | 1 | 2012 | 133 | 0.100 |
Why?
| Down-Regulation | 1 | 2012 | 349 | 0.100 |
Why?
| Diet Surveys | 2 | 2022 | 32 | 0.090 |
Why?
| Longitudinal Studies | 3 | 2022 | 673 | 0.090 |
Why?
| Puerto Rico | 2 | 2019 | 15 | 0.090 |
Why?
| Practice Guidelines as Topic | 1 | 2012 | 448 | 0.090 |
Why?
| Muscle, Skeletal | 1 | 2014 | 750 | 0.080 |
Why?
| Heart Defects, Congenital | 1 | 2013 | 592 | 0.070 |
Why?
| Multivariate Analysis | 2 | 2020 | 585 | 0.070 |
Why?
| Life Style | 2 | 2022 | 140 | 0.070 |
Why?
| Databases, Factual | 2 | 2019 | 664 | 0.070 |
Why?
| National Health Programs | 1 | 2023 | 17 | 0.050 |
Why?
| Predictive Value of Tests | 2 | 2017 | 904 | 0.050 |
Why?
| Diet, Vegetarian | 1 | 2022 | 6 | 0.050 |
Why?
| Thinness | 1 | 2022 | 46 | 0.050 |
Why?
| Longevity | 1 | 2022 | 80 | 0.050 |
Why?
| Mortality | 1 | 2021 | 99 | 0.050 |
Why?
| Echocardiography | 2 | 2013 | 378 | 0.040 |
Why?
| Actinomyces | 1 | 2019 | 9 | 0.040 |
Why?
| Poultry | 1 | 2019 | 25 | 0.040 |
Why?
| Reproducibility of Results | 1 | 2023 | 1188 | 0.040 |
Why?
| Receptors, Progesterone | 1 | 2019 | 63 | 0.040 |
Why?
| Receptor, erbB-2 | 1 | 2019 | 73 | 0.040 |
Why?
| Reflex | 1 | 2018 | 31 | 0.040 |
Why?
| Biometry | 1 | 2017 | 21 | 0.040 |
Why?
| DNA Methylation | 1 | 2022 | 548 | 0.040 |
Why?
| Dietary Carbohydrates | 1 | 2018 | 88 | 0.040 |
Why?
| Hemodynamics | 1 | 2018 | 229 | 0.040 |
Why?
| Survival Analysis | 1 | 2018 | 659 | 0.040 |
Why?
| Disease Progression | 1 | 2018 | 822 | 0.030 |
Why?
| Animals | 2 | 2022 | 13150 | 0.030 |
Why?
| Infant | 2 | 2013 | 3551 | 0.030 |
Why?
| Eating | 1 | 2015 | 162 | 0.030 |
Why?
| Refraction, Ocular | 1 | 2014 | 7 | 0.030 |
Why?
| Valsalva Maneuver | 1 | 2013 | 7 | 0.030 |
Why?
| Posture | 1 | 2013 | 59 | 0.030 |
Why?
| Brain | 1 | 2021 | 1309 | 0.030 |
Why?
| Regression Analysis | 1 | 2013 | 395 | 0.030 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 121 | 0.030 |
Why?
| Heart Rate | 1 | 2013 | 292 | 0.030 |
Why?
| Lipoproteins, HDL | 1 | 2011 | 18 | 0.020 |
Why?
| Diastole | 1 | 2010 | 69 | 0.020 |
Why?
| Systole | 1 | 2010 | 68 | 0.020 |
Why?
| Child, Preschool | 1 | 2013 | 3853 | 0.020 |
Why?
| Treatment Outcome | 1 | 2013 | 5138 | 0.010 |
Why?
|
|
Park's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|